ஜெஃப் ஜுபேர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெஃப் ஜுபேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெஃப் ஜுபேர் Today - Breaking & Trending Today

Zuber Lawler's Assessment and Advice on Consolidation at Benzinga's Cannabis Capital Conference


Zuber Lawler has been representing leading cannabis companies for 14 years handling initial public offerings (IPOs), M&As, finance, intellectual property, FDA and other regulatory work and litigation, in addition to representing a long list of iconic Fortune 500 companies, global funds and governmental entities in their international transactions. 
Despite the country’s change in administration and widespread talk of federal legalization, the cannabis industry is complex. However, Zuber Lawler provides trusted and reliable legal representation to mitigate the complexity. 
Well Decorated
Zuber Lawler’s accomplishments are many. The firm was recently named “Cannabis Law Firm of the Year” by Marijuana Venture Magazine and it obtained the second-ever-issued U.S. plant patent for a cannabis strain as well as U.S. utility patents on cannabis processes, machines and formulations. In addition, the firm obtained the first-ever issued “Generally Recognized as Safe� ....

Zuber Lawler , Janet Jackim , Jeff Zuber , Josh Lawler , Cannabis Law Firm Of The Year , Jazz Pharmaceuticals , Ceres Acquisition Corp , Gw Pharmaceuticals , Law Firm , Marijuana Venture Magazine , Cannabis Capital Conference , Ceres Acquisition , Engineering Cannabisdeals , Avoid Common Contract Pitfalls , Partner Janet Jackim , ஜுபேர் சட்டத்தரணி , ஜெஃப் ஜுபேர் , ஜோஷ் சட்டத்தரணி , கஞ்சா சட்டம் நிறுவனம் ஆஃப் தி ஆண்டு , ஜாஸ் மருந்துகள் , சிஇஆர்இஎஸ் கையகப்படுத்தல் கார்ப் , க்வ் மருந்துகள் , சட்டம் நிறுவனம் , மரிஜுவானா துணிகர பத்திரிகை , கஞ்சா மூலதனம் மாநாடு , சிஇஆர்இஎஸ் கையகப்படுத்தல் ,

Premium Cannabis Operator Item 9 Labs to Present at Benzinga Cannabis Capital Conference on February 25, 2021 at 11:30 AM ET


Share this article
Share this article
PHOENIX, Feb. 17, 2021 /PRNewswire/ Item 9 Labs Corp. (OTCQX: INLB) ( Item 9 Labs or the Company ), a vertically integrated cannabis operator that produces premium products, today announced that Andrew Bowden, CEO of Item 9 Labs, will present live to an online audience at the Benzinga Cannabis Capital Conference being held February 25-26, 2021. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis sector.
Item 9 Labs Presentation at Benzinga Cannabis Capital Conference
-  DATE: Thursday, February 25, 2021
-  TIME: 11:30 AM Eastern Time
Bowden will provide an overview of the Company, including its award-winning products, the ongoing operations expansion and other key initiatives, as well as the growth opportunities resulting from the favorable regulatory environment. He also plans to speak in-depth on why franchising is the growth vehicle th ....

United States , Andrew Bowden , Kim Kovacs , Jeff Zuber , Panel Discussion At Benzinga Cannabis Capital Conference , Arcview Group , Labs Corp , Cannabis Group , Benzinga Cannabis Capital Conference , Benzinga Cannabis Capital , Chief Strategy Officer Jeffrey Rass , Zubler Lawler , Del Duca , Engineering Cannabis Deals That Are Built , Avoid Common Contract Pitfalls That Lead , Benzinga Cannabis Hour , Item 9 Labs Corp , Supplementary Medicine , Health Care Amp Hospitals , Small Cap , Trade Show News , Economic News , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ போடன் , கிம் கோவ்யாக்ஸ் , ஜெஃப் ஜுபேர் ,